Generics Industry Experiences Extraordinary First Quarter Due To COVID-19 Crisis
Looking Ahead, Companies Predict Decline In Revenues
Coronavirus-induced stockpiling and advanced prescribing of medicines has resulted in generics companies across the world registering unprecedented growth during the first quarter of 2020. However, many companies predict sales will level off again in the next quarter and beyond. And as demand fluctuates following the COVID-19 outbreak, companies have started taking precautionary measures to avoid supply-chain disruptions.
